Retainer Agreement
info@rosenlegal.com

Fusion Pharm shareholders have an opportunity to recover their investment losses.

Click "Join this Class Action" above.

Attorneys

Fusion Pharm, Inc.

Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of Fusion Pharm, Inc. (OTC: FSPM)  resulting from allegations that Fusion may have issued materially misleading business information to the investing public.

If you purchased shares of Fusion Pharm on or before September 16, 2016 and would like to join the action, please click "Join This Class Action" above.

Press Release

EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Fusion Pharm, Inc. - FSPM

New York, N.Y., October 3, 2016.  Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of Fusion Pharm, Inc. (OTC: FSPM) resulting from allegations that Fusion Pharm may have issued materially misleading business information to the investing public.

On September 16, 2016, the SEC announced fraud charges against Fusion Pharm and its CEO, Scott M. Dittman, among others, for misleading investors by recording and trumpeting revenues for purported sales of PharmPods by round-tripping money from illegal stock sales by hidden affiliates.

Rosen Law Firm is preparing a class action lawsuit to recover losses suffered by Fusion Pharm investors. If you purchased shares of Fusion Pharm on or before September 16, 2016, please visit the firm’s website at http://www.rosenlegal.com/cases-960.html for more information. You may also contact Phillip Kim or Kevin Chan of Rosen Law Firm toll free at 866-767-3653 or via email at pkim@rosenlegal.com or kchan@rosenlegal.com.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm.

Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.

Attorney Advertising.  Prior results do not guarantee a similar outcome.

-------------------------------

Contact Information:

      Laurence Rosen, Esq.
      Phillip Kim, Esq.
      Kevin Chan, Esq.
      The Rosen Law Firm, P.A.
      275 Madison Avenue, 34th Floor
      New York, NY  10016
      Tel: (212) 686-1060
      Toll Free: (866) 767-3653
      Fax: (212) 202-3827
      lrosen@rosenlegal.com
      pkim@rosenlegal.com
      kchan@rosenlegal.com
      www.rosenlegal.com